
æçå®¶ã»ã¬ããŒå°äœç åœäºè ð¿ã誀äœåããè³ãå»åŠæžé¢ ã·ãªãŒãº ã±ã¢ãã²ãã ð¿ãç§ã®è³ã§èµ·ãã£ãããšã ããã¯ãã³ç€Ÿ/ã¡ããŸæåº« ð¿ããã§ããããšãã§ããªããã®éã®äººãæ¶æç€Ÿ ð¿ãã¬ããŒå°äœåèªç¥çãšã¯äœããã¡ããŸæ°æžã»å¯Ÿè«æ¬ ð¿ãå°éå®¶ãªãã§ãã£ãŠã¿ããïŒãªãŒãã³ãã€ã¢ããŒã°ãæ¶æç€Ÿ(å ±è)
颿±
Joined November 2014
- Tweets39.3K
- Following387
- Followers8.3K
- Likes14K
Pinned Tweet
ãšãã»ã€ãèªç¥çãæãçŽãã(æåçµå£é£9æå·)
å
šæç¡æã§èªããŸãâkeidanren.or.jp/journal/montâŠåé ã¯ãèšªåæ¯ç§å»ãã䌺ã£ãã話ã
èªç¥çã®ããæ£è
ããã«å°ã£ãŠããã®ã«ãããããšããããã»ãŒåé¡ãªãæ²»çã§ããããã«ãªãã蚪åãæ¥œãã¿ã«ãªã£ããšâ¢â¢â¢ã
ããªããããªããšããããã ããïŒããšããè¡åãå¢ããŠããæããïŒèªç¥çäžçã®æ©ãæ¹ãã§æ¬äººããèŠããŠããäžçãç¥ãã倫ã«ã¯ã©ãèŠããŠããã®ã ãããšæ³åããŠãè²ã
ãªå·¥å€«ã詊ããŠã¿ã劻ã
äŸïŒæããã«ç®ç«ã€è²ã®ããŒãã貌ã£ããããæŽããããã«
ãïŒè¥å¹Žæ§èªç¥çãšãšãã«æ©ãåã®äººçã
Replying to @miwashoten
劻ã®äŒžä»£ããã¯ç§ä¿ãããšäžç·ã«åå°ã§è¬æŒæŽ»åãè¡ããæ¬äººã®æ°æã¡ãå°éããããšãç°å¢ã工倫ããããšãèŠå®ãããšãäžäººã§æ±ã蟌ãŸãªãããšãªã©ã®ä»è·çµéšã«å ããŠãèªç¥çã«ãªã£ãŠã人ãšã€ãªããã圹å²ããã€ããšã§ã人çããæããããããšãäŒããŠããŸãã
Netflixã§ã俺ã®ããšããªããèšã£ãŠãïŒãã芳çµãã£ãåŸã«ãYouTubeã§ã1é±ééå®å
¬é - èå°ã誰ãç¥ããªã倧ç©ä¿³åªãå®å
šç | 俺ã®ããšããªããèšã£ãŠãïŒãã芳ãã
èå°ã£ãŠåããã ãªâ¢â¢â¢ãšãã ãã èŠå
¥ã£ãŠããŸã£ãã
圹æåºåžã»ç£¯æåæã»äžäºåèãèå°ã§ãã©ããåçŸã3人ã§ã
13æ¥ãŸã§ã
ããã䞻人ãïŒç²Ÿç¥çãªïŒå€ç¬ã«ããªãããã«ã
ãå®å¿ã§ããå®¶åºç°å¢ãäœãã倧åã§ããã
ãšããïŒã€ã®èšèã¯ãã£ãããšå¿ã«å»ãŸããç§ä¿ãããšã®ããããæ¹ã®ããŒã¹ã«ãªããŸãããã
ã¢ã«ããã€ããŒç
ã®èšºææã«å»åž«ãå®¶æã«äŒããèšèãçŽ æŽãããã
ãïŒè¥å¹Žæ§èªç¥ç ãšãšãã«æ©ãåã®äººçã
Tettyå
çã
ãè¥å¹Žæ§èªç¥çãšãšãã«æ©ãåã®äººçããnoteã§ã玹ä»ããã ããŸããŠãèª ã«ããããšãããããŸãðââïž
note.com/t_tetty/n/nc4d47f01âŠ
ãçŸåšã瀟äŒçæé€ãå·®å¥ãè²§å°ãããããšãã£ã瀟äŒç°å¢èŠå ããïŒçµ±å倱調ç ã®çºçãªã¹ã¯ãäºåŸãååŸ©ã«æ·±ãé¢äžããŠããããšã瀺ããšããã³ã¹ãèç©ãããŠããŸãã
åèŠãå·®å¥ã¯å埩ãé»ã¿ãå
æ¬çã§å®å
šãªç€ŸäŒç°å¢ã¯äºé²ã«å¯äžãåŸãããšãæããã«ãªãã€ã€ãããŸããã
ïŒè¥¿ç°æ·³å¿
ïŒç²Ÿç¥çè·
#å°Ÿè€èª åžã#äœèª¿äžè¯ã®çåæŠç¥ ããæªããšããã¯ãããŸããããšèšãããåŸã®ã¢ã¯ã·ã§ã³ãã©ã³ã æèžç€Ÿ
æ²»çæ³ããªãçã¿/çºã/ããŸã/ç²åŽæãªã©ã®æ
¢æ§çäœèª¿äžè¯ã«æ£è
ãšå»åž«ã¯ã©ã察åŠãããããããå
·äœçã«ç€ºããŠãããè¯æžã
ã#ã©ããäœãã#ãªãããªã®å€ããã¯ã©ã€ã³ãã³ãåºãŠãã
æ
¢æ§çäœèª¿äžè¯ã®äººã¯äžå®å®ãªæ°åã»äžå®ãªäžã®äžã§å¢ããŠããã ããã
ïŒæ°è±¡ç
ãšããèšèãã§ããã
ïŒã¬ããŒå°äœåèªç¥ç ãèªåŸç¥çµãé害ãããã®ã§ãæ¥ã
äœèª¿äžè¯ã
å°Ÿè€å»åž«ã®æ¬ã¯ãïŒç§ã®è³ã§èµ·ãã£ãããšãïŒäžèª¿ã«å¯Ÿãã詊è¡é¯èª€ã®èšé²ïŒã«ãéãããšæã£ãã
note.com/hiiguchinaomi/n/n58âŠ
ã第1å·»ã¯ ïŒæè€ççå ããèªèº«ãæãå
¥ããããäœå®¶ãïŒãã¯ã»ã¯ã³ãœ ã®ã芪åãªçŠå§«ããããç¥
ãäœå®¶ã«æãããäœå®¶ãã§ãã ïŒãã§ã³ã»ã»ã©ã³ ãããç¹ã«åŸèŒ©ã®å¥³æ§äœå®¶ããæ¬æãã(ç¥)
ãïŒãã³ã»ã¬ã³ ãããã¯ãããã¿ããªãã®äœå®¶ãããèªãã§è²ã£ã(ç¥ã
ç¹èšãµã€ãkawade.co.jp/kankokubungaku/
æè€ççåããã®å人線蚳éåè¡éå§ãå
š5å·»ãéåœæåŠã®ééå³åçž® | æ¯æ¥æ°è mainichi.jp/articles/2026110âŠ
æ¬ã®è¡šçŽãæç« ãåçä»ãã§SNSã«èŒã£ãŠããã®ãèŠãŠãèäœæš©éåïŒããšæãèè
ãç·šéè
ãåºç瀟ãããã ããã??
å¿æŽããŠããã ããããšã«æ·±ãæè¬ãšåã³ãæããã¯ãã
ãã èè
åãã¿ã€ãã«ã¯å¿
ãåºãããã
é æšããã®èšèãèè
åãåºããã«ç޹ä»ããæçš¿ãèŠãããã©ããã¯å€±ç€Œã ãšç§ã¯æãã
æžåœ±ïŒæ¬ã®è¡šçŽã®åçïŒããæ¬ã®äžã®æç« ã®ç»åãSNSã«èŒããŠããã®ããããŸã話é¡ã«ãªã£ãŠããããã§ããã
ç§ãæžãããèš³ããããããã®ã«é¢ããŠã¯ããããã§ãèŒããŠããã ããŠããŸããŸããïŒå
šããŒãžãšãã¯ãããã«å°ããŸããïŒãåŒçšãšåãã§ãã
æžåãèè
åãèš³è
åãããã·ã§ãããŸããŸãã
ãå
¥é¢äžã«ããåŠã«ãªã£ãããããåŠãç¹°ãè¿ããããã人㯠ïŒã¬ããŒå°äœç
ã«ãªã£ãŠããå¯èœæ§ããããå
é倧äžå»åž«
ããïŒã¬ããŒå°äœåèªç¥çãšã¯äœããã¡ããŸæ°æž/p.63ã
ïŒã¬ããŒå°äœåèªç¥ç ã§ã¯ ïŒããåŠ(äžæçæèé害) ãèµ·ããããããå粟ç¥è¬ã§æªåããããã®ã§ãããåŠã®äºé²ã倧åâ
ããåŠïŒDeliriumïŒ
ããåŠã¯ãè¬ã§æ²»ãããããäºé²ããåå ãåãé€ããæ£è
ã®è³æ©èœãå埩ã§ããç°å¢ãæŽããããšãéèŠã§ããã
Annals of Internal Medicine, October 2026
Golden BP, Vasilevskis EE. Delirium. In the Clinic.
DOI: 10.7326/ANNALS-26-03322
éèŠãã€ã³ã
1. ããåŠã¯é »åºŠãé«ããäºåŸã«ã倧ããªåœ±é¿ãäžãã
ããåŠã¯ãæ¥æ§ã«çºçããçµéäžã«çç¶ãå€åããè³æ©èœé害ã§ããã
é«éœ¢å
¥é¢æ£è
ã®çŽ25%ã«ããåŠãçºçããã
éå¿èæè¡åŸã§ã¯çŽ10ã20%ã«çºçããã
ICUã§ã¯éçæ£è
ã®çŽ50%ãæ¯èŒç軜çã®æ£è
ã§ãçŽ35%ã«èªããããã
以äžã®è»¢åž°ãšã®é¢é£ãå ±åãããŠããã
æœèšå
¥æã®ãªã¹ã¯ïŒçŽ2ã3å
æ»äº¡ãªã¹ã¯ïŒçŽ3å
ãã®åŸã®èªç¥ç蚺æã®ãªã¹ã¯ïŒæå€§çŽ5å
è¡åŸããåŠçºçåŸã6幎éã®èªç¥æ©èœäœäžé床ãçŽ40%éãã£ããšããç ç©¶ãããã
2. ããåŠã¯ãæºåå åããšãèªçºå åãã®çµã¿åããã§çºçãã
æºåå åïŒPredisposing factorsïŒ
æ£è
ãããšããšæã£ãŠããè匱æ§ã§ããã
ã»é«éœ¢
ã»èªç¥çãæ¢åã®èªç¥æ©èœé害
ã»å€çŸæ£äœµå
ã»å€å€äœµçš
ã»ãã€ç
ã»èŠèŠã»èŽèŠé害
ã»ADLäœäž
ã»äœæ é€ãè²§è¡
ã»ã¢ã«ã³ãŒã«ä¹±çšæŽ
èªçºå åïŒPrecipitating factorsïŒ
ã»ææçãæè¡çãè³åäž
ã»æè¡ã麻é
ã»æ°ããªå粟ç¥è¬ã®æäž
ã»çŒç
ã»è±æ°Žãé»è§£è³ªç°åžž
ã»ç¡ç é害
ã»å°¿éãäŸ¿å¡æ
ã»å°¿éã«ããŒãã«ãèº«äœææ
ã»éšé³ãç°å¢å€å
æºåå åãå€ãæ£è
ã»ã©ã軜埮ãªèªçºå åã§ãããåŠãçºçããã
äŸãã°ãå¥åº·ãªè¥å¹Žè
ã§ã¯éçæè¡çãªã©ãèªå ãšãªãäžæ¹ãèªç¥çã®ããè匱é«éœ¢è
ã§ã¯ãæãã¹ã¿ãã³è¬ã1å€è¿œå ããã ãã§ãããåŠãèµ·ããããã
ïŒããåŠã蚺ãããåäžã®åå ã ããæ¢ãã®ã§ã¯ãªããè€æ°ã®èŠå ãéãªã£ãŠããªãããèããã
3. ããåŠã®èšºæã§æãéèŠãªã®ã¯ã泚æé害ã
ããåŠã®äžå¿çãªèªç¥çç¶ã¯ãèšæ¶é害ã§ã¯ãªã泚æé害ïŒinattentionïŒã§ããã
æ£è
ãäŒè©±ã«éäžã§ããªãã質åãéäžã§å¿ããã話é¡ãããããªã©ã®æèŠãéèŠãšãªãã
çç¶ã¯æ°æéããæ°æ¥ã®éã«çºçãã1æ¥ã®äžã§ãå€åããã
æèã¬ãã«ãæ£åžžã«è¿ãæ£è
ã§ããæ³šæé害ãæèã®ãŸãšãŸãã®ãªãã確èªããå¿
èŠãããã
ããããµã€ãã§ç°¡åã«ã§ããæ³šæåæ€æ»
ã»æãéé ã«èšã£ãŠãããã
ã»ææ¥ãéé ã«çããŠãããã
ã»æ°åãéé ã«åŸ©å±ããŠãããã
ã»ç¹å®ã®æåãèãããšãã«åå¿ããŠãããïŒCAM-ICUïŒãäŸãã°ããã¢ã«ãã¡ãããã®æåãé çªã«èªã¿äžããŸãããããAãã®é³ãèãããããç§ã®æãæ¡ã£ãŠãã ããã
4. äœæŽ»ååããåŠãèŠéããªã
ããåŠã«ã¯äž»ã«3ã€ã®ç²Ÿç¥éååãããã
â éæŽ»ååïŒHyperactiveïŒ
è奮ãèœã¡çãã®ãªããæ»æçè¡åãªã©ã
å»çè
ãæ°ã¥ããããã
â¡äœæŽ»ååïŒHypoactiveïŒ
åŸç ãæŽ»åæ§äœäžãåå¿ã®éããç¡æ°åãªã©ã
ãã€ç
ãç²åŽãèªç¥çãšèª€èªãããããã
â¢æ··ååïŒMixedïŒ
éæŽ»åãšäœæŽ»åãæéãšãšãã«å
¥ãæ¿ããã
èšåºçã«ããã¿ãããã
æ¬è«æã§ã¯ãèšåºå»ãããåŠã®çŽ70%ã蚺æã§ããŠããªããšããæšå®ã玹ä»ããŠãããç¹ã«äœæŽ»ååãèªç¥çå䜵äŸãæèŠé害ã®ããæ£è
ã§èŠéããå€ãã
ïŒãå€éã«æŽããæ£è
ãã ãã§ãªãããæšæ¥ãŸã§è©±ããŠããã®ã«ã仿¥ã¯éãã«ç ã£ãŠã°ããããæ£è
ãã«ãããåŠãçãã
5. CAMãš4ATã䜿ããããåŠã系統çã«èšºæãã
CAMïŒConfusion Assessment MethodïŒïŒCAMã¯æ¬¡ã®4é
ç®ã§è©äŸ¡ããã
ã»æ¥æ§çºçãšçç¶ã®å€å
ã»æ³šæé害
ã»æèã®ãŸãšãŸãã®ãªã
ã»æèã¬ãã«ã®å€å
CAMéœæ§ã®æ¡ä»¶ã¯ã1ïŒ2ïŒïŒ3ãŸãã¯4ïŒãã§ããã
3D-CAMïŒæåºŠ95%ãç¹ç°åºŠ94%ãçŽ3åã§å®æœã§ããã
bCAMïŒæåºŠ84%ãç¹ç°åºŠ96%ãçŽ2åã§å®æœã§ããã
4ATïŒæåºŠ88%ãç¹ç°åºŠ88%ãç¹å¥ãªèšç·Žãå°ãªããŠæžã¿ãçè·åž«ãå«ãå¹
åºãè·çš®ã§äœ¿çšããããã
ICUã§ã¯ãCAM-ICUãŸãã¯ICDSCãæšå¥šãããã
ã¹ã¯ãªãŒãã³ã°ã®é »åºŠ
ã»å
¥é¢æã«ããåŠã®å±éºå åãè©äŸ¡ããã
ã»é«ãªã¹ã¯æ£è
ã§ã¯å
¥é¢æã«ã¹ã¯ãªãŒãã³ã°ããã
ã»äžè¬ç
æ£ã§ã¯å°ãªããšã1æ¥1åã
ã»ICUã§ã¯å°ãªããšã1æ¥2åã
ïŒããåŠã¯ããªããšãªãæ§åãããããããšããå°è±¡ã ãã§å€æãããæšæºåãããè©äŸ¡æ³ã䜿çšããã
6. èªç¥çãšããåŠã¯ãã°ãã°å䜵ãã
èªç¥çã¯æ
¢æ§çã»é²è¡æ§ã®èªç¥æ©èœé害ã§ããã
ããåŠã¯æ¥æ§çºçã§ãçç¶ãå€åããã
èªç¥çæ£è
ãæ¥ã«äŒè©±ã§ããªããªã£ãããåŸç ã«ãªã£ããããå Žåãèªç¥çã®é²è¡ã ãã§èª¬æããŠã¯ãããªãã
å
¥é¢äžã®èªç¥çæ£è
ã§ã¯ãçŽ50%ã«ããåŠãéãªã£ãŠãããšå ±åãããŠããã
ããåŠã®æäžã«ãæ°ããªèªç¥çã®ç¢ºå®èšºæãè¡ãã¹ãã§ã¯ãªãã
å®¶æããã®ç
æŽèŽåãæ¥µããŠéèŠ
ã»æ®æ®µã¯ã©ã®çšåºŠäŒè©±ã§ããã®ãã
ã»ãã€ããæ§åãå€ãã£ãã®ãã
ã»æ¥å
å€åããããã
ã»æè¿ãæ°ããè¬ã远å ãããŠããªããã
ã»å
¥é¢åããèªç¥æ©èœäœäžããã£ããã
7. æ€æ»ã¯ãããåŠã®èšºæãã§ã¯ãªããåå æ€çŽ¢ãã®ããã«è¡ã
ããåŠã®èšºæã¯ç
æŽãšèº«äœèšºå¯ã«ãã£ãŠè¡ãã
è¡æ¶²æ€æ»ãç»åæ€æ»ã§ããåŠãã®ãã®ã確å®ããããšã¯ã§ããªãã
åå æ€çŽ¢ã¯ç
æŽããã€ã¿ã«ãµã€ã³ãèº«äœæèŠã«åºã¥ããŠéžæããã
èæ
®ããæ€æ»
è¡ç®ïŒææçãé床貧è¡
é»è§£è³ªïŒç¹ã«Naç°åžž
BUNãCrïŒè±æ°Žãè
æ©èœé害
è¡ç³ïŒäœè¡ç³ãé«è¡ç³
èæ©èœïŒèé害ãèéçŸæ£
èžéšXç·ïŒèºçãå¿äžå
šãªã©ãçãããå Žå
å°¿æ€æ»ã»å°¿å¹é€ïŒå°¿è·¯ææã瀺åããçç¶ãããå Žå
å¿é»å³ïŒå¿çæ¢å¡ãäžæŽè
è¡æ¶²ã¬ã¹ïŒé«COâè¡çãçãããå Žå
é éšCTãMRIã¯å
šäŸã«å¿
èŠã§ã¯ãªãã
以äžã®å Žåã«é éšç»åæ€æ»ãèæ
®ããã
ã»æ°ããªå±æç¥çµçç¶
ã»é éšå€å·
ã»è³åäžãé èå
åºè¡ã®çã
ã»äºæ³å€ã«é·å»¶ããããããã¯åå äžæã®ããåŠ
éããããæ§ãŠãããçºäœãçãããå Žåã«ã¯è³æ³¢æ€æ»ãæ€èšããã
8. ããåŠã®äºé²ã«ã¯å€é¢çãªéè¬ç©çæ³ãæãæå¹
æã匷ããšããã³ã¹ã瀺ãããŠããã®ããå€å åä»å
¥ã«ããããåŠäºé²ã§ããã
Hospital Elder Life ProgramïŒHELPïŒ
以äžã®6ã€ã®å±éºå åãæšçãšããã
ã»èªç¥æ©èœé害
ã»ç¡ç äžè¶³
ã»èº«äœæŽ»åã®äœäž
ã»èŠèŠé害
ã»èŽèŠé害
ã»è±æ°Ž
å
·äœçãªä»å
¥ãšããŠã以äžãæããããã
ã»æèšãã«ã¬ã³ããŒãèšçœ®ããèŠåœèãä¿ã€ã
ã»çŒé¡ãè£èŽåšã䜿çšããã
ã»æ¥äžã¯é¢åºããæ©è¡ãä¿ãã
ã»å€éã®éšé³ãäžèŠãªåŠçœ®ãæžããã
ã»é£äºãæ°Žåæåãæ¯æŽããã
ã»å®¶æãšã®äº€æµãèªç¥çåºæ¿ãå¢ããã
äºé²å¹æ
HELPã®èšåºè©Šéšã§ã¯ãããåŠçºçã®ãªããºæ¯ã¯0.60ïŒ95%ä¿¡é Œåºé0.39ã0.92ïŒã
NNTã¯19
Cochraneã¬ãã¥ãŒã§ã¯ãå€é¢çãªéè¬ç©ä»å
¥ã«ãããäžè¬ç
æ£æ£è
ã®ããåŠçºçãªã¹ã¯ãçŽ43%äœäžããïŒRR 0.57ïŒã
ïŒããåŠäºé²ã®äžå¿ã¯è¬ç©ã§ã¯ãªããç¡ç ãæŽ»åæ§ãæèŠå
¥åãæ é€ãæ°ŽåãèŠåœèãæŽããããšã§ããã
9. è¬ç©ã«ããããåŠäºé²ã¯ååãšããŠæšå¥šãããªã
æç²Ÿç¥ç
è¬ã«ããäºé²å¹æã¯ç¢ºç«ããŠããªãã
ããããªããŒã«ã¯ICUã§ã®ããåŠäºé²ãæ»äº¡çæ¹åã«æå¹ã§ã¯ãªãã
ã¡ã©ããã³ãã©ã¡ã«ããªã³ããå
¥é¢æ£è
å
šè¬ã«ãããäºé²å¹æã¯æç¢ºã§ã¯ãªãã
ã¹ãã¬ããµã³ããªã©ã®ãã¥ã¢ã«ãªã¬ãã·ã³åå®¹äœæ®æè¬ã«ã¯ãäºé²å¹æã®å¯èœæ§ã瀺ãããŠãããããšããã³ã¹ã¯ãŸã ååã§ã¯ãªãã
äžæ¹ã2025幎ã®éäžæ²»çã¬ã€ãã©ã€ã³ã§ã¯ãäœãç¢ºå®æ§ã®ãšããã³ã¹ã«åºã¥ããéçæ£è
ã«å¯Ÿããã¡ã©ããã³äœ¿çšãæšå¥šããŠããã
ïŒç¡ç è¬ãåŠæ¹ããããšãšãããåŠãäºé²ããããšã¯å矩ã§ã¯ãªãã
10. ããåŠã®æ²»çã¯ãåå ã®é€å»ãšæ¯æçæ³ãåºæ¬
ãŸãä¿®æ£å¯èœãªèªçºå åãæ¢ã
ã»ææçã®æ²»ç
ã»è±æ°Žãé»è§£è³ªç°åžžã®è£æ£
ã»äœé
žçŽ è¡çã®æ¹å
ã»çŒçã³ã³ãããŒã«
ã»å°¿éã䟿ç§ãäŸ¿å¡æ ã®è§£é€
ã»ç¡ç ç°å¢ã®æ¹å
ã»äžå¿
èŠãªã«ããŒãã«ãç¹æ»Žã©ã€ã³ã®é€å»
ã»äžå¿
èŠãªèº«äœææã®åé¿
ã»è¬å€æ§ããåŠãçãïŒç¹ã«æ³šæããè¬å€
ãã³ãŸãžã¢ãŒãã³ç³»è¬ãç¡ç é®éè¬ãæã³ãªã³äœçšã®åŒ·ãè¬å€ããªããªã€ãããããã³äœåè¬ãäžéšã®æèè¬ãç¹ã«ãã«ãªããããã³ç³»ãã»ãã§ãã
è¬å€ã®äžæ¢ã»æžéã»ä»£æ¿ãæ€èšããããã ãããªããªã€ããªã©ã¯æ¥ã«äžæ¢ãããšçŒçæªåãé¢è±ãæããããé©åãªèª¿æŽãå¿
èŠã§ããã
ïŒããåŠæ£è
ã«æ°ããè¬ã远å ããåã«ããŸãçŸåšã®è¬å€ãèŠçŽãã
11. æç²Ÿç¥ç
è¬ã¯ãããåŠãã®ãã®ãæ²»çããè¬ã§ã¯ãªã
ããåŠãæ¹åããããšã確ç«ãããè¬ç©çæ³ã¯ãªãã
ããããªããŒã«ãéå®åæç²Ÿç¥ç
è¬ã¯ãããåŠã®çµéãäºåŸãæ¹åãããšããååãªèšŒæ ããªãã
æç²Ÿç¥ç
è¬ã«ãã£ãŠè奮ãé®éãããŠããããåŠãã®ãã®ãæ¹åãããšã¯éããªãã
æç²Ÿç¥ç
è¬ãèæ
®ããç¶æ³
ã»æ£è
èªèº«ãå»çè
ã«å±éºãåã¶å Žåã
ã»åŒ·ãè奮ã«ãã£ãŠå¿
èŠãªå»çè¡çºã宿œã§ããªãå Žåã
ã»éè¬ç©çãªé®éã»å®å¿ã®æäŸãåå ã®ä¿®æ£ãè¡ã£ãŠããå®å
šã確ä¿ã§ããªãå Žåã
ã»åŒ·ãè奮ã«ãã£ãŠå¿
èŠãªå»çè¡çºã宿œã§ããªãå Žåã
ã»éè¬ç©çãªé®éã»å®å¿ã®æäŸãåå ã®ä¿®æ£ãè¡ã£ãŠããå®å
šã確ä¿ã§ããªãå Žåã
äœ¿çšæã®æ³šæç¹
æå°æå¹éããå¯èœãªéãçæé䜿çšããã
éé®éãQTå»¶é·ã誀å¥ãæ»äº¡ãªã¹ã¯ãªã©ã«æ³šæããã
ããŒãã³ãœããºã ãã¬ããŒå°äœåèªç¥çã§ã¯ããããªããŒã«ãé¿ããã
ã¢ã«ã·ãžã¢ã«ããèœã¡çãã®ãªãããããåŠã®æªåãšèª€èªããªãã
12. ICUããåŠã§ã¯ãã¯ã¹ã¡ããããžã³ãéžæè¢ãšãªã
ICUã§ãéè¬ç©çä»å
¥ãåºæ¬ãšãªãã
人工åŒåžç®¡çäžã®æ£è
ã§ã¯ããã¯ã¹ã¡ããããžã³ãä»ã®é®éè¬ãšæ¯èŒããŠããåŠãªã¹ã¯ãäœäžãããå¯èœæ§ãããã
æ¬è«æã玹ä»ãã2025幎ã®éäžæ²»çã¬ã€ãã©ã€ã³ã§ã¯ã人工åŒåžç®¡çæ£è
ã®é®éã«ãããŠãããããã©ãŒã«ãããã¯ã¹ã¡ããããžã³ãæ¡ä»¶ä»ãã§æšå¥šããŠããã
ãã ããåŸèãäœè¡å§ã«æ³šæããã
ICUã§ã¯ABCDEFãã³ãã«ã«ããå
æ¬çãªç®¡çãéèŠã§ããã
13. èº«äœææã¯ããåŠãæªåãããå¯èœæ§ããã
転åã耥ç¡ãçéªšæ Œç³»ã®æå·ãªã©ã®æå®³äºè±¡ãåé¡ãšãªãã
ååãšããŠãæ¬äººãåšå²ã«å·®ãè¿«ã£ãå±éºãããå Žåã«éå®ããã
ææãå¿
èŠãšãªã£ãå Žåããç¶ç¶ã®å¿
èŠæ§ãç¹°ãè¿ãè©äŸ¡ããã
ææã®åã«ãçŒçãå°¿éã䟿ç§ã空è
¹ãäžå®ãäžèŠãªã«ããŒãã«ãªã©ãè奮ãåŒãèµ·ãããŠããèŠå ã確èªããã
14. ããåŠã¯éé¢åŸãé·æé圱é¿ãã
ããåŠã¯æ°é±éããæ°ãææç¶ããå Žåãããã
é颿ã«çç¶ãæ®åããŠããæ£è
ã§ã¯ãç¶ç¶çãªè©äŸ¡ã𿝿Žãå¿
èŠã§ããã
èªç¥æ©èœãADLã粟ç¥çç¶ãªã©ããã©ããŒããã
çºçãã1ã2ãæçµéããŠãèªç¥æ©èœãADLãå
ã«æ»ããªãå Žåã¯ãè幎å»åŠçãªå
æ¬è©äŸ¡ãç¥çµå¿çåŠçæ€æ»ãæ€èšããã
ããåŠããå埩ããŠããåå
¥é¢ãæè¡ã®éã«ã¯åçºãªã¹ã¯ãé«ãã
Take-home messages
ã»ããåŠãçã£ããããŸãæ®æ®µã®èªç¥æ©èœã𿥿§ã®å€åã確èªããã
ã»éãã«ç ã£ãŠããæ£è
ã«ããäœæŽ»ååããåŠãçãã
ã»èšºæã«ã¯æ³šæé害ã®è©äŸ¡ãäžå¯æ¬ ã§ããã
ã»åå ãæ¢ããå€é¢çãªéè¬ç©çæ³ãåªå
ããã
ã»æç²Ÿç¥ç
è¬ã«ããé®éãšãããåŠã®æ²»çãæ··åããªãã
æ§ã
ãªçç¶ã¯ãè³ã®è¡°ãããšããŠèª¬æãããããã©ãé¯èŠã ïŒãã¬ã€ããªã¢ïŒäººã®é¡ã«èŠããïŒã¯è³ã®ç¹å®ã®éšåãéæã«ãªã£ãŠãããšæããã
ïŒã¬ããŒå°äœç
ã«ãªã£ãŠããå
ãé³ãžã®éæãå§ãŸã£ãã
ãã㯠ïŒçºéé害 ã®çç¶ã«éãããšãã
ïŒã¬ããŒå°äœåèªç¥ç ã§èµ·ããããããã¬ã€ããªã¢ã®äŸâ
æšæ¥ããããããšãããå·»ãããªã¢ã«ãªèã«èŠããã
é¯èŠãšåŒã°ããçç¶ã
ãã£ãšé©ããããéå±ã®èŒªã£ãã«å€ãã£ãã
æšã®æãªã©ãé·ããã®ã¯ããèã«èŠããããã©ãäžžããã®ãèã«èŠããã®ã¯åããŠãã§ãããã£ãœãã
è·¯äžã®å€§ããªæšã®èã¯å€§æµåç©ã«èŠããã
60代ã§ç®èŠãŸããæŽ»èºãããŠãã人ïŒå人ã§ãèžèœäººã§ãïŒã®è©±ãèããšã20代ã®é ãèªåãå±ããéå£ã®äžã§èªåãäžçªãã¡ã§ãæ¬åœã«ã¿ããã§ãã€ããã£ããšèªãã
ããããã®é·å¹Žã«ãããåªåããããã£ãããã ããã©â¢â¢â¢ã
ãèªå·±è¯å®æãäœãããšããèšèãèããã³ã«ã圌ãã®è©±ãæãåºãã
3人ãšãèšæ¶é害ã¯åŒ·ããªããå¥ã®è³æ©èœé害ãããã
ãèªç¥çïŒèšæ¶é害ããšèª°ããæã£ãŠããããã©ã
ãèªç¥çïŒè³æ©èœé害ããšæããã°ãå€ããã¯ãããã«ããæ¬äººã®å°ãäºã課é¡ãæŽã¿ããããªãã
ïŒã¬ããŒå°äœåèªç¥ç ã®çç¶ã¯ #ADHD ïŒçºéé害 ã®ïŒã€ïŒãšéãªããã®ãå€ãã
ïŒæ³šæé害 ãªã©
ã¢ã«ããã€ããŒåèªç¥çãš43æ³ã§èšºæããã ïŒããšãã¿ã ãããïŒå¹Žçµã£ãŠãã©ããšãã»ã€ãåºçã
39æ³ã§åç
ã蚺æããã ïŒäž¹éæºæ ããã41æ³ã§èšºæããã ïŒå±±äžãã®ã¶ ãã(åŸã«ã¬ããŒå°äœåèªç¥çãšèšºæ)ã
幎æ°ãçµã£ãŠãå
æ°ã«æŽ»èºããŠãã人ãã¡ã®ååšãç¥ãã°ããã®ç
æ°ãžã®èŠæ¹ãå€ãã
ã¢ã«ããã€ããŒåèªç¥çãš43æ³ã§èšºæããã ïŒããšãã¿ã ãããïŒå¹Žçµã£ãŠãã©ããšãã»ã€ãåºçã
39æ³ã§åç
ã蚺æããã ïŒäž¹éæºæ ããã41æ³ã§èšºæããã ïŒå±±äžãã®ã¶ ãã(åŸã«ã¬ããŒå°äœåèªç¥çãšèšºæ)ã
幎æ°ãçµã£ãŠãå
æ°ã«æŽ»èºããŠãã人ãã¡ã®ååšãç¥ãã°ããã®ç
æ°ãžã®èŠæ¹ãå€ãã
Replying to @miki_clover4
æéã®ãå±ãã¯ãã¡ãð€
 ̄V ̄ ̄ ̄ ̄ ̄ ̄ ̄ ̄ ̄ ̄
æ¯æ¥ã宿¢ã
å¿ããŠããç§ããèŠã€ããŠãã幞ãð
43æ³ã§è¥å¹Žæ§èªç¥çãšèšºæãããèè
ããæ¥ã
ã®æ®ããã®ãªãã§èŠã€ãã幞ããäŒãããã©ããšãã»ã€ã
蚺æåŸã«å§ããè¶£å³ã仲éãšã®åºäŒãã倢ãåžæâŠ
#èªç¥ç
chuohoki.co.jp/site/g/g82430âŠ
11æ21æ¥ïŒåïŒ18:30ããZoom
ãã¬ããŒå°äœåèªç¥çãµããŒããããã¯ãŒã¯(DLBSN)äžéãäž»å¬ã®è¬æŒäŒã»äº€æµäŒ
ã¬ããŒå°äœç
ïŒ#ã¬ããŒå°äœåèªç¥ç ã» #ããŒãã³ãœã³ç
ãä»ïŒã®ã#ããŒãã³ãœã³çç¶ãã«ã€ããŠãããŒã ã§ã§ããããããã®ã±ã¢ãçéŽå·è¡å»åž«ïŒç¥çµå
ç§å»ïŒããè¬æŒ
å
šåœã©ãªãã§ãð
æšæ¥ããããããšãããå·»ãããªã¢ã«ãªèã«èŠããã
é¯èŠãšåŒã°ããçç¶ã
ãã£ãšé©ããããéå±ã®èŒªã£ãã«å€ãã£ãã
æšã®æãªã©ãé·ããã®ã¯ããèã«èŠããããã©ãäžžããã®ãèã«èŠããã®ã¯åããŠãã§ãããã£ãœãã
è·¯äžã®å€§ããªæšã®èã¯å€§æµåç©ã«èŠããã
ãïŒã±ã¢ãšæŒæãæ¥œãã¿ã
ãã©ãããŠã奜ãã«ãªããªã芪æã奜ãã«ãªãå¿
èŠã¯ãªãããã 仲ã®è¯å¥œãªé¢ä¿ãæŒæããã°ããããšãæãäœãã®æ¬ã§èªãã§æãããã
æ¬å¿ã«ãã ãã£ããã§ããªãèšåãæŒæãªãã§ããã
ããã§ç¶æ³ãæ¹åããŠãäºã楜ã«ãªããªãããã
å·ã€ãåã£ãŠèŠãã¿ç¶ããããããã£ãš
ããã»ãã»ã§ã»ããã¢ã³ãœããŒãã芳åãæåã
åäœçµµæ¬ïŒïŒãšããã®ã¢ã³ãœããŒïŒã¯æã»çµµãšã ïŒå°æåå ããïŒç²Ÿç¥ç§å»ïŒã
èªç¥çã®æ¯ã®ä»è·ã«è¿œãè©°ããããã¢ã³ãœããŒãã©ããªãµãã«åžæãèŠã€ããŠããããšããç©èªã
ãã»ãã»ã§ã»ããã«å§ãŸãèªç¥çä»è·ã®ãšãã»ã³ã¹ã¯æ¬åœã«éèŠïŒåçå³ïŒã
å°æååããïŒç²Ÿç¥ç§å»ïŒåäœïŒãïŒãšããã®ã¢ã³ãœããŒãïŒã®æŒåããã»ãã»ã§ã»ããã¢ã³ãœããŒãã芳ãŠããŸããã
çŽ æŽãããã£ãã§ãïŒ
䞻人å
¬ã¯èªç¥çä»è·ã§è¿œãè©°ããããŠããã¢ã³ãœããŒã
ãã»ãã»ã§ã»ãããå§ãŸãã¢ããã€ã¹ã¯æ¬åœã«å€§åãªãšãã»ã³ã¹ã
å
šåœã§äžæŒãããŠã»ãã倧åãªäœåã
æ¬æ¥ãã€ãã«æ¬çªã§ãã
ããããèããã°
å Žåœãããã²ããããçµãã£ãã®ã§ã
ã€ãŸãæŒåºãšããŠã®ä»äºã¯
ãã¹ãŠå®äºããŠããããã§ãã
ããšã¯å°æ¬ãæžãããã®ãšããŠ
èå°ã®è¡æ¹ãèŠå®ãã«
å°ç°åäžã®äžžããŒã«ãŸã§åããŸãã
ãã®èå°ããå°ãã§ã
èªç¥çä»è·åé¡ã®è§£æ±ºã«
å¯äžã§ããŸãããã«ã
2幎åã®èšäºãå¶ç¶èŠãã
æãããã ïŒæ¹è¶ ã飲ãã§ããã®ã§ããããã
ãè¶éã®å
çã¯èªç¥çã«ãªã人ãå°ãªãããšè¥ãé èããããšãä¹
ãã¶ãã«æãåºããã
ã§ãæ¹è¶ã®å€äžãããããããŠæ²ããã
1æ¥1æ¯ã®æ¹è¶ã軜床èªç¥é害ãç¡ç ã®è³ªã«å¹æ
#ç¡ç #èªç¥ç
forbesjapan.com/articles/detâŠ
ãåšå²ã®éé³ããé¢ããã·ã§ã«ã¿ãŒã®ãããªå Žæã§èªåãšäžå¯Ÿäžã«ãªãéããªæéãåŸãããããšã®è²Žéãã«æ°ã¥ãå§ããã®ãããããŸããããå¹³å®ã®æä»£ãã人éã¯ãããã£ãŠå€ç¬ãªæéã®äžã§èªåãèããŠãããã ãããªãšæããã§ããã©ãäžçš®å€ç¬ã§ããããšãå¿å°ããæéãæ¥èšãæžãããšã§åŸãããã
ãªããšãªãäžæ¥ãçµããããã®ã§ã¯ãªããã²ãšã€ãäžžããã€ããããšã§ãŸãææ¥ãåŸ
ã£ãŠãããã ãªãšæã£ãŠç ãã«ã€ããããã幞çŠã®äžã€ã®åœ¢ããªãšæããŸããã
äœå®¶ã®å°å·æŽåãããæ¥èšãšã¯ãäžå¯Ÿäžã§èªåãèãå€ç¬ã®æéãïŒææ¥æ°è asahi.com/articles/ASVBV471FâŠ























